US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.9796
- +0.0710+7.81%
Trading Nov 27 10:22 ET
285.38MMarket Cap-5155P/E (TTM)
1.0100High0.9270Low2.04MVolume0.9300Open0.9086Pre Close2.00MTurnover0.71%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High7.05P/B281.50MFloat Cap0.360052wk Low--Dividend TTM287.37MShs Float778.1999Historical High--Div YieldTTM9.14%Amplitude0.1700Historical Low0.9800Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ocugen Stock Forum
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet